Vivo Capital

United States
The firm is a 25-year-old global investment firm focused on healthcare with approximately $5.8 billion in AUM, which we have invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, with offices in Asia. Our team consists of 50 multi-disciplinary professionals, including, physicians, scientists,entrepreneurs, operating executives, and industry experts. The firm operates as a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.
Founded:1996
Firm Location:United States • Massachusetts • San Francisco, California • Irvine, California • Palo Alto, California • Menlo Park, California • Beijing • Los Altos, California • Hong Kong • Taiwan • Shanghai • San Francisco Bay Area
Vivo Capital Team
Photo of Gaurav Aggarwal, Managing Director at Vivo Capital
Gaurav Aggarwal
Vivo Capital·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Chen Bian, Associate at Vivo Capital
Chen Bian
Vivo Capital·Associate
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in San Francisco (CA), Investors in Shanghai
Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Pharmaceuticals
Photo of Michael Chang, Partner at Vivo Capital
Michael Chang
Vivo Capital·Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals
Photo of Kevin dai, Managing Director at Vivo Capital
Kevin dai
Vivo Capital·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in San Francisco (CA)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Nathan Dau, Managing Director at Vivo Capital
Nathan Dau
Vivo Capital·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in San Francisco Bay Area (Other Lists)
Photo of DanDan Dong, Managing Director at Vivo Capital
DanDan Dong
Vivo Capital·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Shanghai, Investors in Palo Alto (CA)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in San Francisco Bay Area (Other Lists)
Photo of Edgar Engleman, Managing Partner at Vivo Capital
Edgar Engleman
Vivo Capital·Managing Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Frank Kung, Managing Partner at Vivo Capital
Frank Kung
Vivo Capital·Managing Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Xiaoyang li, Associate at Vivo Capital
Xiaoyang li
Vivo Capital·Associate
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Investors in BioTech, Investors in Medical Devices
Photo of Yixuan Li, Senior Associate at Vivo Capital
Yixuan Li
Vivo Capital·Senior Associate
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Marketplaces
Photo of David Liu, Managing Director at Vivo Capital
David Liu
Vivo Capital·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Taiwan, Investors in Shanghai, Investors in Beijing, Investors in Palo Alto (CA)
Investors in Pharmaceuticals
Photo of Zhongyi Lu, Principal at Vivo Capital
Zhongyi Lu
Vivo Capital·Principal
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Investors in Consumer Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT
Photo of Hongbo Lu, Partner at Vivo Capital
Hongbo Lu
Vivo Capital·Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Jan Møller Mikkelsen, Advisor at Vivo Capital
Jan Møller Mikkelsen
Vivo Capital·Advisor
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in San Francisco (CA)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Katera Mujadidi, Principal at Vivo Capital
Katera Mujadidi
Vivo Capital·Principal
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in San Francisco (CA)
Investors in Consumer Internet, Investors in Enterprise, Investors in San Francisco Bay Area (Other Lists)
Photo of Jack Nielsen, Partner at Vivo Capital
Jack Nielsen
Vivo Capital·Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Fabianne Nordenson, Principal at Vivo Capital
Fabianne Nordenson
Vivo Capital·Principal
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Investors in BioTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in San Francisco Bay Area (Other Lists)
Photo of Daniel Qin, Associate at Vivo Capital
Daniel Qin
Vivo Capital·Associate
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Investors in Marketplaces, Investors in San Francisco Bay Area (Other Lists), Investors in Security
Photo of Mahendra Shah, Investor at Vivo Capital
Mahendra Shah
Vivo Capital·Investor
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in San Francisco (CA)
Photo of Jo Shen, Venture Partner at Vivo Capital
Jo Shen
Vivo Capital·Venture Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in San Francisco (CA)
Investors in Pharmaceuticals
Photo of Joseph Siletto, Managing Director at Vivo Capital
Joseph Siletto
Vivo Capital·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Massachusetts, Investors in San Francisco (CA)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Pharmaceuticals
Photo of Priscilla Sugianto, Senior Associate at Vivo Capital
Priscilla Sugianto
Vivo Capital·Senior Associate
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Santa Monica (CA), Investors in United States
Investors in BioTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices
Photo of Yuh-geng Tsay, Venture Partner at Vivo Capital
Yuh-geng Tsay
Vivo Capital·Venture Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Scott Whitcup, Venture Partner at Vivo Capital
Scott Whitcup
Vivo Capital·Venture Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Photo of Daisy Xu, Managing Director at Vivo Capital
Daisy Xu
Vivo Capital·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Taiwan, Investors in Palo Alto (CA), Investors in Shanghai
Investors in BioTech, Investors in Medical Devices
Photo of Chloe Zhang, Principal at Vivo Capital
Chloe Zhang
Vivo Capital·Principal
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Beijing, Investors in Shanghai, Investors in Hong Kong, Investors in Taiwan, Investors in Palo Alto (CA)
Investors in BioTech, Investors in Medical Devices, Investors in Pharmaceuticals
Photo of Lingfei Zhao, Associate at Vivo Capital
Lingfei Zhao
Vivo Capital·Associate
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Palo Alto (CA)
Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in San Francisco Bay Area (Other Lists)